| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
Megan M Sperry
|
Dec 02, 2023
|
|||||||
| GSM7848948 |
thioridazine-treated, small group, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848949 |
thioridazine-treated, small group, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848950 |
thioridazine-treated, small group, sample 3
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848951 |
thioridazine-treated, large group, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848952 |
thioridazine-treated, large group, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848953 |
thioridazine-treated, large group, sample 3
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848954 |
control, small group, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848955 |
control, small group, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848956 |
control, small group, sample 3
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848957 |
control, large group, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848958 |
control, large group, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848959 |
control, large group, sample 3
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848960 |
thioridazine-treated, small group, stage 35, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848961 |
thioridazine-treated, small group, stage 35, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848962 |
thioridazine-treated, small group, stage 35, sample 3
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848963 |
control, small group, stage 35, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848964 |
control, small group, stage 35, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848965 |
control, small group, stage 35, sample 3
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848966 |
thioridazine-treated, large group, stage 35, sample 1
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 | ||||
| GSM7848967 |
thioridazine-treated, large group, stage 35, sample 2
|
SRA | 1 | Megan M Sperry | Dec 02, 2023 |
